Eyetronic

1 known investors

Eyetronic develops a non-invasive electrical stimulation therapy and system for patients with progressive visual field loss caused by glaucoma or other optic nerve diseases. The CE-marked therapy applies alternating pulses to stimulate retinal ganglion cell neurons and is offered in selected European treatment centers.